TETRACORE, INC.

TETRACORE, INC. specializes in the research and development of advanced molecular diagnostics for high-consequence infectious diseases, with a focus on rapid, point-of-care detection platforms. The company leverages cutting-edge biotechnological methods to design and validate nucleic acid-based assays capable of identifying pathogens such as African swine fever virus and Treponema pallidum in low-resource settings. Their technical expertise includes assay optimization, target sequence analysis, sample preparation protocols, and field-deployable molecular diagnostics, with an emphasis on sensitivity, specificity, and turnaround time. TETRACORE differentiates itself through its ability to translate complex virological and bacteriological research into practical, deployable diagnostic tools that meet the operational needs of field and clinical environments. The contractor has delivered mission-critical R&D services to the U.S. Department of Agriculture and the Department of Health and Human Services, addressing zoonotic disease threats and sexually transmitted infections respectively. For USDA, this involves developing field-ready test kits for livestock pathogens to support animal health surveillance and biosecurity. For HHS, the focus is on accelerating diagnostic innovation for human health applications, particularly in sexually transmitted infection detection. These engagements reflect a pattern of responsive, mission-aligned partnerships focused on public health preparedness and veterinary biosecurity. TETRACORE’s primary industry focus is in biotechnology research and development, specifically in infectious disease diagnostics. The company operates at the intersection of molecular biology and applied public health, positioning itself as a niche provider of non-nanobiotech diagnostic solutions for government-funded pathogen surveillance programs. Their market niche lies in bridging laboratory research with real-world deployment for emerging and re-emerging threats. TETRACORE, INC. is a small business based in Rockville, Maryland, with no federal certifications on record. The company maintains a focused, agile structure optimized for rapid R&D cycles in biotechnology, serving federal agencies with specialized scientific services tailored to national health and agricultural security priorities.